Y mAbs Therapeutics (YMAB) — Working Capital to Net Assets Ratio
Y mAbs Therapeutics (YMAB) has a Working Capital to Net Assets ratio of 78.7% as of June 2025. Working capital of $68.84 Million (current assets of $91.79 Million minus current liabilities of $22.95 Million) is measured against net assets of $87.49 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Y mAbs Therapeutics (YMAB) liquidity interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Y mAbs Therapeutics Working Capital to Net Assets (2016–2024)
This chart shows how Y mAbs Therapeutics's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2016 to 2024. As of June 2025, the ratio stands at 78.7%, reflecting working capital of $68.84 Million against net assets of $87.49 Million USD. For the complete balance sheet picture, see total assets of Y mAbs Therapeutics.
Annual Working Capital to Net Assets for Y mAbs Therapeutics (2016–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Y mAbs Therapeutics from 2016 to 2024, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check YMAB asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 81.3% | $74.81 Million | $92.00 Million | $98.51 Million | $23.70 Million | ▼ -8.8 pp |
| 2023 | 90.1% | $90.98 Million | $100.98 Million | $111.11 Million | $20.13 Million | ▼ -3.4 pp |
| 2022 | 93.5% | $102.16 Million | $109.22 Million | $130.45 Million | $28.28 Million | ▼ -3.3 pp |
| 2021 | 96.8% | $174.39 Million | $180.11 Million | $202.26 Million | $27.88 Million | ▼ -0.3 pp |
| 2020 | 97.2% | $102.83 Million | $105.84 Million | $122.36 Million | $19.54 Million | ▼ -2.6 pp |
| 2019 | 99.7% | $198.37 Million | $198.90 Million | $211.96 Million | $13.59 Million | ▼ -1.6 pp |
| 2018 | 101.3% | $142.41 Million | $140.53 Million | $151.53 Million | $9.12 Million | ▼ -0.2 pp |
| 2017 | 101.6% | $83.43 Million | $82.15 Million | $91.36 Million | $7.92 Million | ▼ -16.9 pp |
| 2016 | 118.4% | $14.29 Million | $12.06 Million | $17.26 Million | $2.98 Million | — |